Montis Biosciences

Montis Biosciences
Montis Biosciences
Montis Biosciences is develops novel immune-oncology therapeutics targeting the intersection between vascular dysfunction and immune suppression to treat solid tumours.

Meise
Biotechnology, Therapeutics
Between €5 million-€10 million
2020
montisbiosciences.com/
💡 You’re a corporate or investor and looking for startups that are innovating in the same market as Montis Biosciences? We’re happy to assist you with our Startup Sourcing service.